Business Of Biotech Biotech C-Suite Construction With Allan Shaw
20 snips
Oct 14, 2024 Allan Shaw, a biotech finance guru with decades of experience in strategic hiring and leadership, shares invaluable insights on assembling effective executive teams. He emphasizes the dangers of inadequate hiring and stresses the importance of aligning talent with clinical milestones. The discussion also covers the challenges of preparing for public offerings and navigating fractional versus full-time leadership roles. Shaw reveals how careful decision-making can thrive even in volatility, ensuring that biotech companies remain agile and prepared for growth.
AI Snips
Chapters
Transcript
Episode notes
Fear Distorts Hiring Choices
- Fear and insecurity drive many poor hiring decisions in biotech and create blind spots.
- Expand input from boards and teams to identify real needs before hiring high-cost executives.
Fund Programs Before Full C‑Suite Builds
- Prioritize funding development programs that create value before fully scaling the C‑suite.
- Use fractional executives to buy expertise without committing full-time cost until needed.
Buy Expertise, Not The Whole Cow
- Fractional C‑suite access lets companies get adult supervision without buying the whole cow.
- It reduces upfront overhead while protecting decision quality and extending runway.